Managing Equipment Assets Across Multiple Sites

Orthogonal Methods

Orthogonal Analytics: How Much Characterization Is Enough?

David Alvaro, Ph.D.

Pharma's Almanac

Data-Driven Mfg

Data-Driven Manufacturing and Digital Twins Across the Biologics Network

Jihyeon Oh; Hongwoo Joo

Samsung Biologics

Flow Chemistry

When Flow Chemistry Solves the Manufacturing Problem

Hiroaki Yasukouchi, Ph.D.

Kaneka

AAV Analytics

Advancing AAV Gene Therapies Through Analytical Innovation

Cynthia A. Challener, Ph.D.

Pharma's Almanac

CGT Release

Release Testing as a Cell and Gene Therapy Manufacturing Bottleneck

Pharma's Almanac

Pathfinder

Solid-Phase vs. Liquid-Phase Peptide Synthesis: Which Manufacturing Strategy Is Better?

Nice Insight

Nonviral Delivery

Can Nonviral Delivery Change the Economics of Gene Therapy?

David Alvaro, Ph.D.

Pharma's Almanac

Pathfinder

Spray-Dried Dispersions vs. Nanocrystals: Which Is Better for Solubility Enhancement?

Nice Insight

Viral Vectors

Gene Therapy Manufacturing After the Capacity Boom

David Alvaro, Ph.D.

Pharma's Almanac

New Technology

What are the key bottlenecks preventing rapid adoption of novel technologies?

Pharma's Almanac

Biocatalysis

When Does Biocatalysis Create the Better Manufacturing Process?

Yusho Kato

Kaneka

Pathfinder

Micronization vs. Nanomilling vs. Amorphous Solid Dispersions: Which Is Better for Poorly Soluble Drugs?

Nice Insight